Overview
Welcome to Dwaey, specifically on ROLENIUM ELPENHALER (500+50)mcg Inhaler/Dry Powder page.
This medicine contains an important and useful components, as it consists of Fluticasone Propionate, Salmeterol Xinafoate.
ROLENIUM ELPENHALER (500+50)mcg is available in the market in concentration 500mcg, 50mcg/Dose and in the form of Inhaler/Dry Powder.
ELPEN PHARMACEUTICAL CO. INC. is the producer of ROLENIUM ELPENHALER (500+50)mcg and it is imported from GREECE, The most popular alternatives of ROLENIUM ELPENHALER (500+50)mcg are listed downward .
Salmeterol, a long acting beta 2-agonist which acts locally in the lung to mediate bronchodilation. Fluticasone, a corticosteroid with mainly glucocorticoid activity, reduce symptoms and exacerbations of asthma.
Pulmonary TB, severe cardiovascular disorders, heart rhythm abnormalities, DM, thyrotoxicosis, hypokalaemia. Patients at risk of decreased bone mineral content (e.g. smoking, old age, sedentary lifestyle, poor nutrition, family history of osteoporosis or long term use of drugs that may decrease bone mass (e.g. anticonvulsants and corticosteroids). Do not stop therapy abruptly; therapy should be down titrated. Advise patient to rinse mouth after inhalation. Monitor height of children on prolonged therapy. Pregnancy, lactation.
Not for primary treatment of status asthmaticus or other acute attacks of asthma. Severe hypersensitivity to milk proteins.
Pregnancy category: C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
ROLENIUM ELPENHALER (500+50)mcg
Fluticasone Propionate, Salmeterol Xinafoate
ROLENIUM ELPENHALER (250+50)mcg
Fluticasone Propionate, Salmeterol Xinafoate